Head to Head Survey: Xcorporeal (OTCMKTS:XCRP) and Integer (NYSE:ITGR)

Xcorporeal (OTCMKTS:XCRPGet Free Report) and Integer (NYSE:ITGRGet Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, dividends, valuation, profitability and analyst recommendations.

Valuation and Earnings

This table compares Xcorporeal and Integer”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Xcorporeal N/A N/A N/A N/A N/A
Integer $1.72 billion 2.38 $90.65 million $3.36 36.20

Integer has higher revenue and earnings than Xcorporeal.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for Xcorporeal and Integer, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Xcorporeal 0 0 0 0 0.00
Integer 0 2 7 0 2.78

Integer has a consensus target price of $147.67, indicating a potential upside of 21.41%. Given Integer’s stronger consensus rating and higher probable upside, analysts plainly believe Integer is more favorable than Xcorporeal.

Profitability

This table compares Xcorporeal and Integer’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Xcorporeal N/A N/A N/A
Integer 6.92% 11.65% 5.89%

Insider and Institutional Ownership

99.3% of Integer shares are held by institutional investors. 2.0% of Integer shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Integer beats Xcorporeal on 9 of the 9 factors compared between the two stocks.

About Xcorporeal

(Get Free Report)

Xcorporeal, Inc. is in the process of liquidation and dissolution, pursuant to the plan adopted by board of directors of the company on February 4, 2010. The company has formed the liquidating trust, Xcorporeal, Inc. Liquidating Trust, and transferred all of its assets to the trust for the purpose of completing the liquidation and dissolution of the company. Previously, it operated as a medical device company, which was engaged in the development of an extra-corporeal platform technology to be used in devices to replace the function of various human organs. Xcorporeal, Inc. was founded in 2001 and is based in Lake Forest, California.

About Integer

(Get Free Report)

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.

Receive News & Ratings for Xcorporeal Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xcorporeal and related companies with MarketBeat.com's FREE daily email newsletter.